Pharmacological targeting of adenosine receptor signaling

Mol Aspects Med. 2017 Jun:55:4-8. doi: 10.1016/j.mam.2016.12.002. Epub 2017 Jan 12.

Abstract

Adenosine receptor signaling plays important roles in normal physiology, but is also known to modulate the development or progression of several different diseases. The design of new, efficient, and safe pharmacological approaches to target the adenosine system may have considerable therapeutic potential, but is also associated with many challenges. This review summarizes the main challenges of adenosine receptor targeted treatment including tolerance, disease stage, cell type-specific effects, caffeine intake, adenosine level assessment and receptor distribution in vivo. Moreover, we discuss several potential ways to overcome these obstacles (i.e., the use of partial agonists, indirect receptor targeting, allosteric enhancers, prodrugs, non-receptor-mediated effects, neoreceptors, conditional knockouts). It is important to address these concerns during development of new and successful therapeutic approaches targeting the adenosine system.

Keywords: Adenosine; Adenosine receptor; Disease; Drug discovery; Drug target; Pharmacology.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / agonists
  • Adenosine / antagonists & inhibitors
  • Adenosine / genetics
  • Brain Diseases, Metabolic / drug therapy*
  • Brain Diseases, Metabolic / pathology
  • Humans
  • Molecular Targeted Therapy
  • Prodrugs / therapeutic use
  • Purinergic P1 Receptor Agonists / therapeutic use*
  • Purinergic P1 Receptor Antagonists / therapeutic use*
  • Receptors, Purinergic P1 / genetics*
  • Receptors, Purinergic P1 / metabolism
  • Signal Transduction

Substances

  • Prodrugs
  • Purinergic P1 Receptor Agonists
  • Purinergic P1 Receptor Antagonists
  • Receptors, Purinergic P1
  • Adenosine